vimarsana.com

Latest Breaking News On - Analyst recommendations for amylyx pharmaceuticals - Page 1 : vimarsana.com

Amylyx Pharmaceuticals (NASDAQ:AMLX) Given New $3 00 Price Target at Mizuho

Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price objective reduced by Mizuho from $4.00 to $3.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. A number of other equities research analysts have also weighed in on the company. The Goldman Sachs Group […]

Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Cut to $3 00

Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price target decreased by Mizuho from $4.00 to $3.00 in a report issued on Tuesday, Benzinga reports. Mizuho currently has a neutral rating on the stock. A number of other research firms have also recently weighed in on AMLX. HC Wainwright reaffirmed a buy rating and issued […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.